O-13 Hepatocellular carcinoma patients are advantage in the Brazilian current liver transplant allocation system. A competing risk analysis. A RETROSPECTIVE STUDY

O-13 Hepatocellular carcinoma patients are advantage in the Brazilian current liver transplant allocation system. A competing risk analysis. A RETROSPECTIVE STUDY

Background: In Brazil, the Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for deceased donor liver transplantation (DDLT). Patients with hepatocellular carcinoma (HCC) receive standardized MELD exception points to account for their cancer risk of mortality, which is no...

Full description

Bibliographic Details
Main Authors: Santiago Rodrıguez, Alfeu de Medeiros Fleck, Jr., Marcos Mucenic, Claudio Marroni, Ajacio Brandão
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812100199X

Similar Items

Similar Items